iRhythm Technologies Stock Forecast, Price & News

12 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for iRhythm Technologies in the last year. There are currently 7 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" iRhythm Technologies stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in IRTC, but not buy additional shares or sell existing shares.
View analyst ratings for iRhythm Technologies or view top-rated stocks.

Wall Street analysts have given iRhythm Technologies a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but iRhythm Technologies wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

iRhythm Technologies saw a decrease in short interest in March. As of March 15th, there was short interest totaling 2,810,000 shares, a decrease of 14.6% from the February 28th total of 3,290,000 shares. Based on an average daily volume of 603,000 shares, the days-to-cover ratio is presently 4.7 days.
View iRhythm Technologies' Short Interest.

iRhythm Technologies is scheduled to release its next quarterly earnings announcement on Thursday, May 6th 2021.
View our earnings forecast for iRhythm Technologies.

iRhythm Technologies, Inc. (NASDAQ:IRTC) announced its earnings results on Thursday, February, 25th. The company reported ($0.33) earnings per share for the quarter, missing the consensus estimate of ($0.31) by $0.02. iRhythm Technologies had a negative net margin of 20.97% and a negative trailing twelve-month return on equity of 28.89%.
View iRhythm Technologies' earnings history.

iRhythm Technologies' stock was trading at $85.54 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, IRTC shares have increased by 6.1% and is now trading at $90.76.
View which stocks have been most impacted by COVID-19.

12 Wall Street analysts have issued 1 year price targets for iRhythm Technologies' shares. Their forecasts range from $80.00 to $273.00. On average, they expect iRhythm Technologies' share price to reach $171.77 in the next year. This suggests a possible upside of 89.3% from the stock's current price.
View analysts' price targets for iRhythm Technologies or view top-rated stocks among Wall Street analysts.

20 employees have rated iRhythm Technologies CEO Kevin M. King on Glassdoor.com. Kevin M. King has an approval rating of 91% among iRhythm Technologies' employees. This puts Kevin M. King in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Some companies that are related to iRhythm Technologies include Penumbra (PEN), Hill-Rom (HRC), Globus Medical (GMED), Inspire Medical Systems (INSP), Haemonetics (HAE), Integra LifeSciences (IART), Tandem Diabetes Care (TNDM), Inari Medical (NARI), Nevro (NVRO), ShockWave Medical (SWAV), ICU Medical (ICUI), Glaukos (GKOS), Cantel Medical (CMD), NuVasive (NUVA) and Merit Medical Systems (MMSI).
View all of IRTC's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other iRhythm Technologies investors own include NVIDIA (NVDA), Alibaba Group (BABA), salesforce.com (CRM), Square (SQ), Teladoc Health (TDOC), The Trade Desk (TTD), Advanced Micro Devices (AMD), Intel (INTC), Broadcom (AVGO) and The Boeing (BA).

(IRTC) raised $76 million in an initial public offering (IPO) on Thursday, October 20th 2016. The company issued 5,400,000 shares at $13.00-$15.00 per share. J.P. Morgan and Morgan Stanley served as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

iRhythm Technologies trades on the NASDAQ under the ticker symbol "IRTC."

Shares of IRTC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of IRTC stock can currently be purchased for approximately $90.76.

iRhythm Technologies has a market capitalization of $2.65 billion and generates $214.55 million in revenue each year. The company earns $-54,570,000.00 in net income (profit) each year or ($2.16) on an earnings per share basis.

iRhythm Technologies employs 1,157 workers across the globe.

The official website for iRhythm Technologies is www.irhythmtech.com.

iRhythm Technologies is headquartered at 650 TOWNSEND STREET SUITE 500, San Francisco CA, 94103.

iRhythm Technologies' mailing address is 650 TOWNSEND STREET SUITE 500, San Francisco CA, 94103. The company can be reached via phone at 415-632-5700 or via email at [email protected]